Tang Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Tang Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,000	Closed	-$269K	–	117
2023 Q1	$269K	Sell	50,000 -150,000	-75%	-$816K	0.04%	92
2022 Q4	$742K	Hold	200,000	–	–	0.11%	74
2022 Q3	$1M	Hold	200,000	–	–	0.12%	84
2022 Q2	$1.17M	Buy	+200,000	New	+$1.13M	0.18%	61

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Tang Capital Management's ORTX Position: Q2 2023 in Review

Tang Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2023, closing a stake of 50,000 shares — an estimated $269K sold.

Tang Capital Management first reported a position in ORTX in Q2 2022 and held it in 4 quarters. The position peaked at $1.17M in Q2 2022. 33 funds tracked by Wall St. Rank hold ORTX as of Q2 2023.

Tang Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Tang Capital Management sold 50,000 Orchard Therapeutics plc American Depositary Shares shares in Q2 2023, an estimated $269K.
Tang Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2022 and held it in 4 quarters.
Tang Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.17M in Q2 2022.
33 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2023.

Based on Tang Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.